<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101093791</journal-id>
<journal-id journal-id-type="pubmed-jr-id">30240</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Diab Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Diab. Rep.</journal-id>
<journal-title-group>
<journal-title>Current diabetes reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1534-4827</issn>
<issn pub-type="epub">1539-0829</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29896650</article-id>
<article-id pub-id-type="pmc">6341981</article-id>
<article-id pub-id-type="doi">10.1007/s11892-018-1016-2</article-id>
<article-id pub-id-type="manuscript">NIHMS1001288</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Congenital Diabetes: Comprehensive Genetic Testing Allows for
Improved Diagnosis and Treatment of Diabetes and Other Associated
Features</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Letourneau</surname>
<given-names>Lisa R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greeley</surname>
<given-names>Siri Atma W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<!--<email>sgreeley@peds.bsd.uchicago.edu</email>-->
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Section of Adult and Pediatric Endocrinology, Diabetes and
Metabolism, Kovler Diabetes Center, The University of Chicago, MC 1027/N235; 5841 S.
Maryland Ave., Chicago, IL 60637, USA</aff>
<author-notes>
<fn fn-type="COI-statement" id="FN1">
<p id="P45">Compliance with Ethical Standards</p>
<p id="P46"><bold>Conflict of Interest</bold> Lisa R. Letourneau and Siri Atma W.
Greeley report funding of investigator-initiated research from Novo Nordisk.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<day>13</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>18</volume>
<issue>7</issue>
<fpage>46</fpage>
<lpage>46</lpage>
<!--elocation-id from pubmed: 10.1007/s11892-018-1016-2-->
<abstract id="ABS1">
<sec id="S1">
<title>Purpose of Review</title>
<p id="P1">The goal of this review is to provide updates on congenital
(neonatal) diabetes from 2011 to present, with an emphasis on publications
from 2015 to present.</p>
</sec>
<sec id="S2">
<title>Recent Findings</title>
<p id="P2">There has been continued worldwide progress in uncovering the genetic
causes of diabetes presenting within the first year of life, including the
recognition of nine new causes since 2011. Management has continued to be
refined based on underlying molecular cause, and longer-term experience has
provided better understanding of the effectiveness, safety, and
sustainability of treatment. Associated conditions have been further
clarified, such as neurodevelopmental delays and pancreatic insufficiency,
including a better appreciation for how these “secondary”
conditions impact quality of life for patients and their families.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">While continued research is essential to understand all forms of
congenital diabetes, these cases remain a compelling example of personalized
genetic medicine.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Neonatal diabetes</kwd>
<kwd>Congenital diabetes</kwd>
<kwd>Monogenic diabetes</kwd>
<kwd>NDM</kwd>
<kwd>PNDM</kwd>
<kwd>TNDM</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>